We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+12.03%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$1.04T
AUM Growth
+$136B
Cap. Flow
+$33.3B
Cap. Flow %
3.19%
Top 10 Hldgs %
19.7%
Holding
8,129
New
701
Increased
3,666
Reduced
2,249
Closed
619

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Healthcare 9.65%
3 Financials 9.27%
4 Consumer Discretionary 8.86%
5 Industrials 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
6676
Tempest Therapeutics
TPST
$18.7M
$484 ﹤0.01%
+8
New +$379
COYA icon
6677
Coya Therapeutics
COYA
$110M
$482 ﹤0.01%
65
+60
+1,200% +$333
QUBT icon
6678
Quantum Computing Inc
QUBT
$2.02B
$477 ﹤0.01%
+522
New +$448
HIVE
6679
HIVE Digital Technologies
HIVE
$706M
$467 ﹤0.01%
103
+3
+3% +$10
LARK icon
6680
Landmark Bancorp
LARK
$197M
$465 ﹤0.01%
26
-1
-4% -$16
DSM
6681
BNY Mellon Strategic Municipal Bond Fund
DSM
$291M
$463 ﹤0.01%
81
-2,962
-97% -$15.5K
FTH
6682
Faeth Therapeutics
FTH
$738M
$462 ﹤0.01%
33
ALGS icon
6683
Aligos Therapeutics
ALGS
$42.3M
$450 ﹤0.01%
27
PMN icon
6684
ProMIS Neurosciences
PMN
$133M
$446 ﹤0.01%
16
KRON
6685
DELISTED
Kronos Bio
KRON
$438 ﹤0.01%
350
-1,171
-77% -$1.3K
TYGO icon
6686
Tigo Energy
TYGO
$96.7M
$437 ﹤0.01%
+209
New +$611
CTMX icon
6687
CytomX Therapeutics
CTMX
$730M
$436 ﹤0.01%
281
-1,449
-84% -$1.91K
OPAL icon
6688
OPAL Fuels
OPAL
$67.7M
$436 ﹤0.01%
79
-43
-35% -$266
IZEA icon
6689
IZEA Worldwide
IZEA
$53.8M
$432 ﹤0.01%
215
+7
+3% +$16
PHUN icon
6690
Phunware
PHUN
$43.4M
$427 ﹤0.01%
104
+2
+2% +$14
DNTH icon
6691
Dianthus Therapeutics
DNTH
$6.13B
$426 ﹤0.01%
41
HELP
6692
Cybin Inc
HELP
$710M
$424 ﹤0.01%
27
+19
+238% +$354
INSG icon
6693
Inseego
INSG
$77.7M
$418 ﹤0.01%
190
-3,093
-94% -$9.31K
NRGU icon
6694
MicroSectors U.S. Big Oil 3x Leveraged ETNs due Feb 17 2045
NRGU
$24M
$414 ﹤0.01%
1
WATT icon
6695
Energous
WATT
$82M
$414 ﹤0.01%
8
CTSO icon
6696
Cytosorbents Corp
CTSO
$22.8M
$413 ﹤0.01%
372
VIRX
6697
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$411 ﹤0.01%
721
PROV icon
6698
Provident Financial
PROV
$113M
$404 ﹤0.01%
32
TAYD icon
6699
Taylor Devices
TAYD
$170M
$398 ﹤0.01%
18
+14
+350% +$314
TECX
6700
Tectonic Therapeutic
TECX
$664M
$384 ﹤0.01%
24
-6,961
-100% -$120K

Similar funds

JP Morgan Chase's Q4 2023 Portfolio in Review

As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.

  • JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
  • JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
  • JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
  • JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
  • JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
  • JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.